Author

Bassam Albashiti

Observed names: B Albashiti, B. Albashiti

Observed institutions: Mayo Clinic, Johns Hopkins University, Wayne State University, Johns Hopkins Medicine, Detroit Medical Center, The Barbara Ann Karmanos Cancer Institute, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Mayo Clinic in Florida, Johns Hopkins Hospital, Mayo Clinic Comprehensive Cancer Center (Minnesota), Mayo Clinic Comprehensive Cancer Center (Florida)

OpenAlex ID: A5061215933

Characteristics and survival of head and neck cancer by HPV status: a cancer registry‐based study

2011 · Seema Sethi, Rouba Ali‐Fehmi, et al. · International Journal of Cancer · 103

Glut-1 Expression Correlates with Basal-like Breast Cancer

2011 · Yaser R. Hussein, Sudeshna Bandyopadhyay, et al. · Translational Oncology · 92

Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer

2012 · Yaser R. Hussein, Anil K. Sood, et al. · Human Pathology · 58

Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

2012 · Michele L. Cote, Julie J. Ruterbusch, et al. · Cancer Prevention Research · 42

Extensive meningeal enhancement in acute central nervous system Lyme: Case series and review of literature

2019 · Mahbobeh Niksefat, Bassam Albashiti, et al. · Journal of Clinical Neuroscience · 7

Clinical Characteristics of Breast Cancers in African-American Women with Benign Breast Disease: A Comparison to the Surveillance, Epidemiology, and End Results Program

2014 · Susanna D. Mitro, Rouba Ali-Fehmi, et al. · The Breast Journal · 6

Data from Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

2023 · Michele L. Cote, Julie J. Ruterbusch, et al.

Supplementary Table 1 from Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

2023 · Michele L. Cote, Julie J. Ruterbusch, et al.

Supplementary Table 1 from Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

2023 · Michele L. Cote, Julie J. Ruterbusch, et al.

Data from Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

2023 · Michele L. Cote, Julie J. Ruterbusch, et al.

Abstract B39: Clinical characteristics of breast cancers in African American women with benign breast disease: A comparison to the Surveillance, Epidemiology and End Results Program

2014 · Susanna D. Mitro, Rouba Ali-Fehmi, et al. · Cancer Epidemiology Biomarkers & Prevention

P1-08-16: Benign Breast Disease (BBD) and Breast Cancer in African American Women.

2011 · RA Fehmi, M Cote, et al. · Cancer Research

P2-11-07: Expression of Selected Predictive Markers in African American Women with Atypical Hyperplasia of the Breast.

2011 · S Bandyopadhyay, M Cote, et al. · Cancer Research

The concordance of estrogen and progesterone receptor status (ER-PR) and HER2/neu expression in DCIS coexistent with micro-invasive and invasive carcinoma.

2010 · R. Ali-Fehmi, Z. A. Nahleh, et al. · Journal of Clinical Oncology

Mixed type endometrial carcinoma: Clinicopathologic comparison between two large academic institutions.

2010 · S. Bandyopadhyay, S. Sethi, et al. · Journal of Clinical Oncology

Works count: 15

Citation count: 308

H-index: 6

I10-index: 4